Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q2 2026 · 10-Q
Revenue$60.74M$60.74M+5.0% vs Q2 2025 Net Income$2.48M$2.48M−27.8% vs Q2 2025 EPS Diluted$0.45$0.45−28.6% vs Q2 2025 Gross Profit$37,331,000+5.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flowderived$8,222,000+56.0% Free Cash Flowderived$7,130,000+104.7% Margins · derivedGross margin61.5%+0.2 pt vs Q2 2025
Operating margin7.8%+1.7 pt vs Q2 2025
Net margin4.1%−1.9 pt vs Q2 2025
ended Sep 30, 2025 · filed Nov 6, 2025 · 37 d after period end